Sundrug Income Statement

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Revenue	842,512	801,811	751,777	690,462	648,734
Revenue Growth (YoY)	5.08%	6.65%	8.88%	6.43%	2.27%
Cost of Revenue	626,341	597,723	562,457	518,516	492,228
Gross Profit	216,171	204,088	189,320	171,946	156,506
Selling, General & Admin	150,578	142,309	133,294	134,492	122,454
Operating Expenses	169,338	159,591	148,323	134,495	122,454
Operating Income	46,833	44,497	40,997	37,451	34,052
Interest Expense	-384	-164	-32	-36	-9
Interest & Investment Income	244	160	127	125	128
Earnings From Equity Investments	-1,258	-1,567	-	-	-
Other Non Operating Income (Expenses)	785	908	636	594	563
EBT Excluding Unusual Items	46,220	43,834	41,728	38,134	34,734
Gain (Loss) on Sale of Investments	-	198	-	-	-
Gain (Loss) on Sale of Assets	84	-6	21	144	232
Asset Writedown	-900	-998	-856	-864	-282
Other Unusual Items	399	540	367	296	-10
Pretax Income	45,803	43,568	41,260	37,710	34,674
Income Tax Expense	14,411	12,818	12,134	12,007	10,821
Net Income	31,392	30,750	29,126	25,703	23,853
Net Income to Common	31,392	30,750	29,126	25,703	23,853
Net Income Growth	2.09%	5.58%	13.32%	7.76%	-5.83%
Shares Outstanding (Basic)	117	117	117	117	117
Shares Outstanding (Diluted)	117	117	117	117	117
Shares Change (YoY)	0.01%	0.02%	0.01%	0.01%	0.00%
EPS (Basic)	268.36	262.90	249.06	219.83	204.02
EPS (Diluted)	268.36	262.90	249.06	219.82	204.01
EPS Growth	2.07%	5.56%	13.30%	7.75%	-5.83%
Free Cash Flow	12,961	7,713	4,762	12,591	12,857
Free Cash Flow Per Share	110.80	65.94	40.72	107.68	109.96
Dividend Per Share	-	130.000	114.000	100.000	71.000
Dividend Growth	-	14.04%	14.00%	40.84%	1.43%
Gross Margin	25.66%	25.45%	25.18%	24.90%	24.13%
Operating Margin	5.56%	5.55%	5.45%	5.42%	5.25%
Profit Margin	3.73%	3.84%	3.87%	3.72%	3.68%
Free Cash Flow Margin	1.54%	0.96%	0.63%	1.82%	1.98%
EBITDA	65,593	61,779	56,124	49,519	44,261
EBITDA Margin	7.79%	7.70%	7.47%	7.17%	6.82%
D&A For EBITDA	18,760	17,282	15,127	12,068	10,209
EBIT	46,833	44,497	40,997	37,451	34,052
EBIT Margin	5.56%	5.55%	5.45%	5.42%	5.25%
Effective Tax Rate	31.46%	29.42%	29.41%	31.84%	31.21%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.